Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
Irreversible electroporation (IRE) has been approved as ablation therapy for pancreatic ductal adenocarcinoma (PDAC). Here, the authors show that, in mouse models, IRE reverses the immunosuppressive microenvironment of PDAC resulting in increased and durable response when combined with PD1 checkpoin...
Guardado en:
Autores principales: | Jun Zhao, Xiaofei Wen, Li Tian, Tingting Li, Chunyu Xu, Xiaoxia Wen, Marites P. Melancon, Sanjay Gupta, Baozhong Shen, Weiyi Peng, Chun Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6997acb67b654db0a21d5b14ff520bda |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer
por: He C, et al.
Publicado: (2021) -
Identification of Circulating Biomarkers and Construction of a Prognostic Signature for Survival Prediction in Locally Advanced Pancreatic Cancer After Irreversible Electroporation
por: He C, et al.
Publicado: (2021) -
Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation
por: Alissa Hendricks-Wenger, et al.
Publicado: (2021) -
Irreversible electroporation of human primary uveal melanoma in enucleated eyes.
por: Yossi Mandel, et al.
Publicado: (2013) -
Effects of osmotic pressure on the irreversible electroporation in giant lipid vesicles.
por: Malay Kumar Sarkar, et al.
Publicado: (2021)